Articles In Press                   Back to the articles list | Back to browse issues page

XML Print

1- Department of Microbiology, Assistant Professor, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, India ,
2- Department of Microbiology, Ex- Professor, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, India
3- Department of Microbiology, Associate Professor, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, India
Abstract:   (238 Views)
Background and Aim: The study was conducted to assess the role of Nitric Oxide (NO) in the pathogenesis of Dengue fever (DF).
Materials and Methods: A total of 150 patients with positive Dengue serology and 50 candidates as controls in the age group of 15-65 years were included in the study. NO levels were measured by Griess Nitrate Method (Cadmium granules modified).
Results: The rise in NO was observed in 24 (20.86%) patients out of 115 DF patients, while it was raised in only 01 (2.8%) case out of 35 patients of DHF and the difference was observed to be statistically significant. NO level was within normal limits (Normal Range- 24.8-77.6µmol/L) in 92% (n=50) healthy controls and was raised in (NO value>77.66µmol/L) 4% healthy controls. A positive correlation was observed in the serum NO levels with platelet count. The majority of the patients in the study (41.44%) were in the age group of 21-30 years of age, followed by were < 20 yrs (30%) and 31-40 yrs (12.67%). Male:female ratio observed was 1.78:1. DF was diagnosed in 115 (76.67%) patients, while DHF was diagnosed in 35 (23.33%) patients, while no case of DSS was diagnosed.
Conclusion: NO plays a protective role in DF, while in DHF patients, the absence of rising NO levels may be one of the contributory factors leading to the progression of the disease and increased morbidity. NO levels can guide the physician about the evolution of a case of Dengue.
Article number: 5
Type of Study: Original Research Article | Subject: Medical Virology
Received: 2022/03/25 | Accepted: 2022/07/12 | ePublished: 2022/09/9

1. Guzman M, Halstead S, Artsob H, Buchy P, Farrar J, Gubler D, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(S12):S7-16. [DOI:10.1038/nrmicro2460] [PMID] [PMCID]
2. Organization WH. Dengue guidelines for diagnosis, treatment, prevention and control 2009.
3. Habermehl G. Toxicon. Am J trop Med Hyg. 1983;21(5):734. [DOI:10.1016/0041-0101(83)90293-3]
4. Sabchareon A, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, et al. Dengue Infection in Children in Ratchaburi, Thailand: A Cohort Study. I. Epidemiology of Symptomatic Acute Dengue Infection in Children, 2006-2009. PLoS Neglected Tropical Diseases. 2012;6(7):e1732. [DOI:10.1371/journal.pntd.0001732] [PMID] [PMCID]
5. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol. 1991;41(4):485-90. [DOI:10.1016/0006-2952(91)90618-F]
6. Moncada S, Palmer RMJ, Higgs EA. Biosynthesis of nitric oxide from l-arginine: A pathway for the regulation of cell function and communication. Biochem Pharmacol. 1989;38(11):1709-15. [DOI:10.1016/0006-2952(89)90403-6]
7. Moncada S, Higgs A. The L-Arginine-Nitric Oxide Pathway. N Engl J Med. 1993;329(27):2002-12. [DOI:10.1056/NEJM199312303292706] [PMID]
8. Bogdan C. The Multiplex Function of Nitric Oxide in (Auto) immunity. J Exp Med. 1998;187(9):1361-5. [DOI:10.1084/jem.187.9.1361] [PMID] [PMCID]
9. Akaike T, Maeda H. Nitric oxide and virus infection. Immunology. 2000;101(3):300-8. [DOI:10.1046/j.1365-2567.2000.00142.x] [PMID] [PMCID]
10. Akuta T, Zaki MH, Yoshitake J, Okamoto T, Akaike T. Nitrative stress through formation of 8-nitroguanosine: Insights into microbial pathogenesis. Nitric Oxide. 2006;14(2):101-8. [DOI:10.1016/j.niox.2005.10.004] [PMID]
11. Valero N, Espina LM, Torres E, Mosquera J. increased level of serum nitric oxide in patients with dengue. Am J Trop Med Hyg. 2002;66(6):762-4. [DOI:10.4269/ajtmh.2002.66.762] [PMID]
12. IVD Kit MiI. Medical Devices J. Mitra [Internet]. 2021.
13. Organization WH. Dengue Guidelines for Diagnosis Treatment, Prevention and Control A joint publication of the World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases (TDR)2009.
14. Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's principles of internal medicine. 19 ed: Mcgraw-hill New York, NY, USA; 2015.
15. Organization WH. Dengue guideline, for diagnosis, treatment, prevention and control Who. 2009.
16. Jameson JL, Fauci A, Kasper D, Hauser S, Longo D, Loscalzo J. Harrison's Principles of Internal Medicine. 20, editor2022.
17. Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med. 2007;43(5):645-57. [DOI:10.1016/j.freeradbiomed.2007.04.026] [PMID] [PMCID]
18. Quijano C, Romero N, Radi R. Tyrosine nitration by superoxide and nitric oxide fluxes in biological systems: Modeling the impact of superoxide dismutase and nitric oxide diffusion. Free Radic Biol Med. 2005;39(6):728-41. [DOI:10.1016/j.freeradbiomed.2005.04.014] [PMID]
19. Ignarro LJ, Sisodia M, Trinh K, Bedrood S, Wu G, Wei LH, et al. Nebivolol inhibits vascular smooth muscle cell proliferation by mechanisms involving nitric oxide but not cyclic GMP. Nitric oxide. 2002;7(2):83-90. [DOI:10.1016/S1089-8603(02)00113-1]
20. Kumar A, Pandit VR, Shetty S, Pattanshetty S, Krish SN, Roy S. A profile of dengue cases admitted to a tertiary care hospital in Karnataka, southern India. Trop Doct. 2010;40(1):45-6. [DOI:10.1258/td.2009.080376] [PMID]
21. Tejaswi CN, Patil SS, Shekharappa KR. Study of clinical manifestations of dengue cases in a tertiary care hospital, Bangalore, Karnataka. Int J Medical Sci Public Health. 2016;5(12):2503-7. [DOI:10.5455/ijmsph.2016.07052016504]
22. Thai KTD, Nishiura H, Hoang PL, Tran NTT, Phan GT, Le HQ, et al. Age-specificity of clinical dengue during primary and secondary infections. PLoS Negl Trop Dis. 2011;5(6):e1180. [DOI:10.1371/journal.pntd.0001180] [PMID] [PMCID]
23. Sheu J-R, Kan Y-C, Hung W-C, Lin C-H, Yen M-H. The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase. Life Sci. 2000;67(8):937-47. [DOI:10.1016/S0024-3205(00)00686-X]
24. Shukla R, Ramasamy V, Shanmugam RK, Ahuja R, Khanna N. Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine. Front Cell Infect Microbiol. 2020:597. [DOI:10.3389/fcimb.2020.572681] [PMID] [PMCID]
25. Singh R, Singh SP, Ahmad N. A study of clinical and laboratory profile of dengue fever in a tertiary care centre of Uttarakhend, India. Int J Res Med Sci. 2014;2(1):160-63. [DOI:10.5455/2320-6012.ijrms20140232]
26. Thein S, Aaskov J, Myint TT, Shwe TN, Saw TT, Zaw A. Changes in levels of anti‐dengue virus IgG subclasses in patients with disease of varying severity. Journal of medical virology. 1993;40(2):102-6. [DOI:10.1002/jmv.1890400205] [PMID]
27. Resna R, Aryati A, Wardhani P, Triyono E. Nilai diagnostik anti dengue iga dan ns1, serta igm/igg di infeksi virus dengue (the diagnostic value of anti dengue iga and anti dengue igm/igg in dengue virus infection). Indones J Clinical Pathol Med Laboratory. 2018;21(1):82-9. [DOI:10.24293/ijcpml.v21i1.1264]
28. Raj AS, Munshi S, Shah BH. A study on clinical presentation of dengue fever in children. Int J Sci Res. 2016;5(4):2272-5. [DOI:10.21275/v5i4.NOV163048]
29. Valero N, Espina L, Torres E, Mosquera J. increased level of serum nitric oxide in patients with dengue. Am J Trop Med Hyg. 2002;66(6):762-4. [DOI:10.4269/ajtmh.2002.66.762] [PMID]
30. Marianneau P, Steffan AM, Royer C, Drouet MT, Jaeck D, Kirn A, et al. Interaction of dengue virus with human kupffer cells in vitro. Biol Cell. 1999;91(3):280. [DOI:10.1016/S0248-4900(99)80058-6]
31. Mukerjee R, Misra A, Chaturvedi UC. Dengue virus‐induced cytotoxin releases nitrite by spleen cells. Int J Exp Pathol. 1996;77(2):45-51. [DOI:10.1046/j.1365-2613.1996.962100.x] [PMID] [PMCID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc